Shares in Britain’s AstraZeneca opened 2% lower on Monday after a report it had approached U.S. rival Gilead Sciences about a possible merger to form one the world’s largest drug companies.
Source:: Reuters – Business News
Shares in Britain’s AstraZeneca opened 2% lower on Monday after a report it had approached U.S. rival Gilead Sciences about a possible merger to form one the world’s largest drug companies.
Source:: Reuters – Business News
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.